Published by Michele Maatouk on 21st December 2020
(Sharecast News) - Agios Pharmaceuticals said on Monday that it has agreed to sell its commercial, clinical and research-stage oncology portfolio to independent global pharmaceutical company Servier for as much as $2bn.
URL: http://www.digitallook.com/dl/news/story/31530084/...